Search - tctmd.com

Displaying 141 - 160 of 297

Sort: Relevancy | Date

Top News in Policy & Practice: 2018

News Features

Top News in Policy & Practice: 2018

December 28, 2018

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

News Daily News

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

December 21, 2018

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

News Daily News

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

November 15, 2018

News Conference News AHA 2018

AHA Puts Focus on the Impact of Violence on Cardiovascular Health

November 14, 2018

News Industry News

CardioMech Appoints Richard Nehm as President and CEO, and Mark Novotny as Chairman

November 06, 2018

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

News Daily News

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Michael O'Riordan

October 25, 2018

New Point-of-Care Troponin Assay Shows Promise for Ruling Out MI

News Daily News

New Point-of-Care Troponin Assay Shows Promise for Ruling Out MI

October 17, 2018

Silent Infarcts Have Similar Mortality Over 10 Years as Clinically Recognized MI

News Daily News

Silent Infarcts Have Similar Mortality Over 10 Years as Clinically Recognized MI

Yael L. Maxwell

October 10, 2018

News Industry News

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

September 05, 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

June 21, 2018

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

News Daily News

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

June 04, 2018

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

News Daily News

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

May 04, 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

News Conference News ACC 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Michael O'Riordan

March 14, 2018

Shorter, Lower-Dose Ultrasound-Accelerated Thrombolysis for Acute PE Keeps Early Promise: OPTALYSE PE

News Conference News ISET 2018

Shorter, Lower-Dose Ultrasound-Accelerated Thrombolysis for Acute PE Keeps Early Promise: OPTALYSE PE

February 06, 2018

News Industry News

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

January 24, 2018

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

News Conference News AHA 2017

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

Yael L. Maxwell

November 27, 2017

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

News Conference News ESC 2017

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

Michael O'Riordan

August 29, 2017

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

News Daily News

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

August 18, 2017

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.